The Leukemia & Lymphoma Society, Inc. v. The Walter and Eliza Hall Institute of Medical Research

District Court, S.D. New York·Decided October 23, 2024·No. 1:22-cv-10690·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK THE LEUKEMIA & LYMPHOMA SOCIETY, INC. Case No. 22-CV-10690-NRB Plaintiff, v. JOINT STIPULATION AND [PROPOSED] PROTECTIVE THE WALTER AND ELIZA HALL ORDER INSTITUTE OF MEDICAL RESEARCH, Defendant. NAOMI REICE BUCHWALD, United States District Judge: WHEREAS, the parties to this action (collectively, the “Parties,” and individually, a “Party”) request that this Court issue a protective order pursuant to Federal Rule of Civil Procedure 26(c) to protect the confidentiality of certain nonpublic and confidential material that will likely be exchanged pursuant to and during the course of discovery in this case; WHEREAS, the Parties, through counsel, agree to the following terms; and WHEREAS, this Court finds good cause for issuance of an appropriately tailored confidentiality order governing the pretrial phase of this action; IT IS HEREBY ORDERED that any Party or person subject to this Protective Order— including without limitation the Parties to this action, their representatives, agents, experts and consultants, and all non-parties providing discovery in this action,—shall adhere to and be protected by the following terms: 1. Any Party or person subject to this Protective Order who receives from any other Party subject to this Protective Order any “Discovery Material” (i.e., information of any kind - including documents, Electronically stored information (ESI) or testimony produced or disclosed pursuant to and in the course of discovery in this action) that is designated as “Confidential” pursuant to the terms of this Protective Order (hereinafter “Confidential Discovery Material”) shall not disclose such Confidential Discovery Material to anyone else except as expressly permitted hereunder. 2. The Party producing any given Discovery Material (each, “Producing Party”) may

designate as Confidential any document that it reasonably and in good faith believes consists of: a. Research, technical, commercial, or financial information that the Producing Party has maintained as confidential; b. Information that any Party is under a contractual obligation to maintain as confidential; c. information prohibited from disclosure by statute; d. Personally Identifiable Information; or e. any other category of information that the Parties agree is confidential or that is given confidential status by this Court, upon application by a Party or otherwise,

after the date of this Order. 3. With respect to the Confidential portion of any Discovery Material other than deposition transcripts and exhibits, the Producing Party or that Party’s counsel may designate such portion as “Confidential” by stamping or otherwise clearly marking the document in a manner that will not interfere with legibility or audibility. 4. All depositions shall presumptively be treated as Confidential subject to this Protective Order during the deposition and until thirty days after receipt by counsel of the transcript, unless otherwise agreed to by the Parties. This thirty day period may be extended or shortened by agreement of the Parties. Upon informing all Parties of the portions of a deposition that are to be designated as Confidential during the thirty day period, the designating Party shall notify the stenographer of those designations and shall take all reasonable steps to ensure that, within seven days, the stenographer circulates a copy of the transcript with a cover that contains a prominent notice that the transcript contains Confidential Information and an index noting the page and line references of any such designations. The Confidentiality of those designations

shall not be deemed to be waived if the stenographer does not circulate such a copy within seven days of receiving notification of the designations by the designating Party. 5. Inadvertent or unintentional disclosure of Confidential Discovery Material, or failure to designate a document as “Confidential,” shall not be deemed a waiver in whole or in part of a claim to the protection of this Protective Order. If at any time prior to decision on a summary judgement motion (if any) or, if no summary judgment motion is filed, trial of this action, a Producing Party realizes that Discovery Material that it had previously produced without limitation should be designated as Confidential, it may so designate by promptly apprising all prior recipients of the Discovery Material in writing, and such designated Discovery

Material will thereafter be deemed to be and treated as Confidential Discovery Material with the revised designation indicated under the terms of this Protective Order. In addition, the Producing Party shall provide each other Party with replacement copies of such Discovery Material that bear the “Confidential” designation within five business days of providing such notice. 6. Nothing contained in this Order will be construed as: (a) a waiver by a Party or person of its right to object to any discovery request; (b) a waiver of any privilege or protection; or (c) a ruling regarding the admissibility at trial of any document, testimony, or other evidence. 7. No Party or person subject to this Protective Order other than the Producing Party shall disclose any of the Discovery Material designated by the producing person as Confidential to any other person whomsoever, except to: a. the Parties to this action, including in-house counsel providing assistance in this action, and their insurers, and counsel to their insurers;

b. outside counsel retained specifically for this action, including any paralegal, clerical, and other assistant employed by such counsel; c. outside vendors or service providers (such as copy-service providers and document-management consultants, graphic production services, e-discovery vendors, or other litigation support services) that counsel hire and assign to this matter; d. any mediator or arbitrator that the Parties engage in this matter or that this Court appoints; e. as to any document, its author, its addressee, and any other person indicated on

the face of the document as having received a copy; f. any non-party witness who counsel for a Party in good faith believes may be called to testify at trial or deposition in this action, provided such person has first executed a Non-Disclosure Agreement in the form annexed as an Exhibit hereto; g. any person retained by a Party to serve as an expert witness or otherwise provide specialized advice to counsel in connection with this action (including employees, associates, or clerical personnel assisting the expert) , provided such person has first executed a Non-Disclosure Agreement in the form annexed as an Exhibit hereto; h. Other individuals, upon written agreement by the Parties and only after the individual(s) has executed a Non-Disclosure Agreement in the form annexed as Exhibit A hereto; i. stenographers and videographers engaged to transcribe or record depositions conducted in this action; and

j. this Court, including any appellate court, and the court reporters and support personnel for the same. 8. Prior to any disclosure of any Confidential Discovery Material to any person referred to in subparagraphs 7(f)-(h) above, counsel for the Receiving Party must first provide a copy of this Order to such person, who must sign a Non-Disclosure Agreement in the form annexed as Exhibit A hereto stating that he or she has read this Order and agrees to be bound by its terms. Counsel must retain each signed Non-Disclosure Agreement through the termination of this action, including appeals. . 9. Disclosure of any Confidential Discovery Material designated as to any person

Free access — add to your briefcase to read the full text and ask questions with AI

The Leukemia & Lymphoma Society, Inc. v. The Walter and Eliza Hall Institute of Medical Research, (S.D.N.Y. 2024).

The Leukemia & Lymphoma Society, Inc. v. The Walter and Eliza Hall Institute of Medical Research (The Leukemia & Lymphoma Society, Inc. v. The Walter and Eliza Hall Institute of Medical Research) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Lugosch v. Pyramid Co. of Onondaga
435 F.3d 110 (Second Circuit, 2006)